206 related articles for article (PubMed ID: 21124423)
1. Complex synthesis yields breast-cancer therapy.
Ledford H
Nature; 2010 Dec; 468(7324):608-9. PubMed ID: 21124423
[No Abstract] [Full Text] [Related]
2. Eribulin mesylate in the management of metastatic breast cancer and other solid cancers: a drug review.
Polastro L; Aftimos PG; Awada A
Expert Rev Anticancer Ther; 2014 Jun; 14(6):649-65. PubMed ID: 24852360
[TBL] [Abstract][Full Text] [Related]
3. The halichondrins and E7389.
Jackson KL; Henderson JA; Phillips AJ
Chem Rev; 2009 Jul; 109(7):3044-79. PubMed ID: 19534494
[No Abstract] [Full Text] [Related]
4. Eribulin mesylate.
Huyck TK; Gradishar W; Manuguid F; Kirkpatrick P
Nat Rev Drug Discov; 2011 Mar; 10(3):173-4. PubMed ID: 21358731
[No Abstract] [Full Text] [Related]
5. Selected hybrid natural products as tubulin modulators.
Dasari B; Jimmidi R; Arya P
Eur J Med Chem; 2015 Apr; 94():497-508. PubMed ID: 25455639
[TBL] [Abstract][Full Text] [Related]
6. Macrocyclic ketone analogues of halichondrin B.
Zheng W; Seletsky BM; Palme MH; Lydon PJ; Singer LA; Chase CE; Lemelin CA; Shen Y; Davis H; Tremblay L; Towle MJ; Salvato KA; Wels BF; Aalfs KK; Kishi Y; Littlefield BA; Yu MJ
Bioorg Med Chem Lett; 2004 Nov; 14(22):5551-4. PubMed ID: 15482922
[TBL] [Abstract][Full Text] [Related]
7. Eribulin in 'field practice': an overview of the Italian experience.
Barni S
Future Oncol; 2015; 11(15 Suppl):1-2. PubMed ID: 26235257
[No Abstract] [Full Text] [Related]
8. Eribulin, a simplified ketone analog of the tubulin inhibitor halichondrin B, for the potential treatment of cancer.
Newman S
Curr Opin Investig Drugs; 2007 Dec; 8(12):1057-66. PubMed ID: 18058576
[TBL] [Abstract][Full Text] [Related]
9. Editorial: Marine Natural Products themed issue.
Nat Prod Rep; 2011 Feb; 28(2):181. PubMed ID: 21229158
[No Abstract] [Full Text] [Related]
10. Nontaxane microtubule dynamics inhibitors.
Cortes J
Clin Adv Hematol Oncol; 2011 Mar; 9(3):216-7. PubMed ID: 21475127
[No Abstract] [Full Text] [Related]
11. Eribulin mesilate, a halichondrin B analogue, in the treatment of breast cancer.
Mani S; Swami U
Drugs Today (Barc); 2010 Sep; 46(9):641-53. PubMed ID: 20967296
[TBL] [Abstract][Full Text] [Related]
12. Eribulin, a microtubule inhibitor for metastatic breast cancer.
Wilkes GM
Oncology (Williston Park); 2011 Feb; 25(2 Suppl Nurse Ed):46-8. PubMed ID: 25373284
[No Abstract] [Full Text] [Related]
13. Clinical efficacy of eribulin mesylate for the treatment of metastatic soft tissue sarcoma.
Emambux S; Italiano A
Expert Opin Pharmacother; 2017 Jun; 18(8):819-824. PubMed ID: 28468516
[TBL] [Abstract][Full Text] [Related]
14. Second generation synthesis of C27-C35 building block of E7389, a synthetic halichondrin analogue.
Yang YR; Kim DS; Kishi Y
Org Lett; 2009 Oct; 11(20):4516-9. PubMed ID: 19754145
[TBL] [Abstract][Full Text] [Related]
15. [Anti-tumor mechanism and clinical efficacy of Eribulin (Halaven®), a new microtubulin inhibitor approved for treatment of metastatic breast cancer].
Koyama N; Tokunaga T; Ogasawara W; Murakami M; Yamashita Y
Nihon Yakurigaku Zasshi; 2011 Nov; 138(5):209-17. PubMed ID: 22075465
[No Abstract] [Full Text] [Related]
16. Chemistry. The renaissance of natural products as drug candidates.
Paterson I; Anderson EA
Science; 2005 Oct; 310(5747):451-3. PubMed ID: 16239465
[No Abstract] [Full Text] [Related]
17. Eribulin mesylate (Halaven) for breast cancer.
Med Lett Drugs Ther; 2011 Apr; 53(1362):30-1. PubMed ID: 21502935
[TBL] [Abstract][Full Text] [Related]
18. Eribulin mesylate in breast cancer.
Verdaguer H; Morilla I; Urruticoechea A
Womens Health (Lond); 2013 Nov; 9(6):517-26. PubMed ID: 24161305
[TBL] [Abstract][Full Text] [Related]
19. Highly convergent synthesis of peluroside A.
Floreancig PE
Angew Chem Int Ed Engl; 2009; 48(42):7736-9. PubMed ID: 19739167
[No Abstract] [Full Text] [Related]
20. Novel anti-tubulin cytotoxic agents for breast cancer.
Morris PG; Fornier MN
Expert Rev Anticancer Ther; 2009 Feb; 9(2):175-85. PubMed ID: 19192956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
